Concordia International Corp. Grant of Treble Damages Further Vindicates Marketing Rights of its Donnatal® Brand
AMCo (Formerly Amdipharm Mercury Ltd) | March 17, 2017
Concordia International Corp. ("Concordia" or the "Company") (NASDAQ: CXRX) (TSX: CXR), an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products, today announced that a U.S. district court has granted the Company treble damages related to false claims made by Method Pharmaceuticals, LLC ("Method") and its principal owner. All financial references are in U.S. dollars.